Treatment with AG490 (10 μM) inhibited the survival of CLL cells mediated by IFN-γ (Figure 3c) and this inhibition was associated with the downregulation of STAT3 and Mcl-1 proteins (Figure 3d). Here, MCL1 is linked to B-cell chronic lymphocytic leukemia.